[go: up one dir, main page]

MX2018015047A - Metodo para la deteccion de un anticuerpo igm especifico para un flavivirus en una muestra. - Google Patents

Metodo para la deteccion de un anticuerpo igm especifico para un flavivirus en una muestra.

Info

Publication number
MX2018015047A
MX2018015047A MX2018015047A MX2018015047A MX2018015047A MX 2018015047 A MX2018015047 A MX 2018015047A MX 2018015047 A MX2018015047 A MX 2018015047A MX 2018015047 A MX2018015047 A MX 2018015047A MX 2018015047 A MX2018015047 A MX 2018015047A
Authority
MX
Mexico
Prior art keywords
flavivirus
sample
igm
binding
detection
Prior art date
Application number
MX2018015047A
Other languages
English (en)
Other versions
MX374731B (es
Inventor
X Heinz Franz
Stiasny Karin
Original Assignee
Univ Wien Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wien Med filed Critical Univ Wien Med
Publication of MX2018015047A publication Critical patent/MX2018015047A/es
Publication of MX374731B publication Critical patent/MX374731B/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • G01N2333/183Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/185Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe un método para la detección de un anticuerpo IgM específico para un flavivirus en una muestra, que comprende los pasos de a) poner en contacto la muestra con un soporte sólido que comprenda moléculas de unión a IgM inmovilizadas, b) permitir la unión de anticuerpos IgM en la muestra a las moléculas de unión a IgM en el soporte sólido para que los anticuerpos IgM también se inmovilicen en el soporte sólido, y c) detectar anticuerpos IgM específicos para un flavivirus permitiendo la unión de un complejo que comprende i) un dímero antiparalelo de Proteína E de flavivirus soluble ( sE) y ii) un marcador e identificar la unión del complejo al anticuerpo IgM de flavivirus específico detectando el marcador; y un kit adecuado para llevar a cabo el método.
MX2018015047A 2016-06-06 2017-06-02 Método para la detección de un anticuerpo igm específico para un flavivirus en una muestra. MX374731B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16173043 2016-06-06
PCT/EP2017/063446 WO2017211713A1 (en) 2016-06-06 2017-06-02 Method for the detection of an IgM antibody specific for a flavivirus in a sample

Publications (2)

Publication Number Publication Date
MX2018015047A true MX2018015047A (es) 2019-05-13
MX374731B MX374731B (es) 2025-03-06

Family

ID=56148121

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015047A MX374731B (es) 2016-06-06 2017-06-02 Método para la detección de un anticuerpo igm específico para un flavivirus en una muestra.

Country Status (9)

Country Link
US (1) US10591480B2 (es)
EP (1) EP3465206B1 (es)
JP (1) JP6908299B2 (es)
AR (1) AR108771A1 (es)
AU (1) AU2017277065A1 (es)
BR (1) BR112018074620A2 (es)
ES (1) ES2774497T3 (es)
MX (1) MX374731B (es)
WO (1) WO2017211713A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112585468B (zh) * 2018-09-18 2024-09-24 美国西门子医学诊断股份有限公司 用于寨卡病毒免疫测定的方法和试剂
CN110132896A (zh) * 2019-05-06 2019-08-16 山西大学 一种快速检测血清中乳腺癌标志物的微型光纤生物传感器
US12066432B2 (en) 2019-06-05 2024-08-20 Gynuity Health Projects, Inc. Placental protein biomarkers for gestational age assessment and related methods
CN221151747U (zh) * 2023-10-13 2024-06-14 深圳市万欣荣模具塑胶有限公司 电子设备支撑架和带电子设备支撑架的保护壳

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US5077391A (en) 1989-12-01 1991-12-31 Raison Robert L Purification of immunoglobulin M
US5112952A (en) 1990-09-28 1992-05-12 Pierce Chemical Company Composition and method for isolation and purification of Immunoglobulin M
DE69604454T2 (de) 1995-06-21 2000-03-02 Tecnogen S.C.P.A., Piana De Monte Verna Peptidliganden für die konstante Region von Immunoglobulinen
ITMI962628A1 (it) 1996-12-16 1998-06-16 Tecnogen Scpa Composizione farmaceutica
KR20010022452A (ko) * 1997-07-31 2001-03-15 추후제출 플라비바이러스 감염에 대한 재조합 다이머형 엔벨롭 백신
AU6068000A (en) 1999-07-02 2001-01-22 Research And Development Institute, Inc. Peptide ligands that bind igm antibodies and block interaction with antigen
US20040213808A1 (en) * 2002-12-11 2004-10-28 Michael Lieberman Recombinant vaccine against flavivirus infection
US20050287170A1 (en) 2002-12-11 2005-12-29 Hawaii Biotech, Inc. Subunit vaccine against West Nile viral infection
EP2003144A1 (en) 2007-06-15 2008-12-17 Institut Pasteur Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
EP2272860A1 (en) 2009-07-10 2011-01-12 Institut Pasteur Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections
GB201413086D0 (en) 2014-07-23 2014-09-03 Imp Innovations Ltd And Inst Pasteur Methods
EP2980099A1 (en) 2014-07-31 2016-02-03 Bernhard-Nocht-Institut für Tropenmedizin Compositions and methods for detecting flaviviridae infections
SG10201404571PA (en) 2014-08-01 2016-03-30 Mp Biomedicals Asia Pacific Pte Ltd Method and kit for detecting a dengue virus infection
EP3009841A1 (en) 2014-10-14 2016-04-20 Bernhard-Nocht-Institut für Tropenmedizin Detection of IgM Antibodies using an immune complex (IC) ELISA

Also Published As

Publication number Publication date
ES2774497T3 (es) 2020-07-21
AU2017277065A1 (en) 2019-01-17
AR108771A1 (es) 2018-09-26
BR112018074620A2 (pt) 2019-03-06
MX374731B (es) 2025-03-06
WO2017211713A1 (en) 2017-12-14
EP3465206A1 (en) 2019-04-10
JP2019527837A (ja) 2019-10-03
US20190170750A1 (en) 2019-06-06
JP6908299B2 (ja) 2021-07-21
EP3465206B1 (en) 2019-12-04
US10591480B2 (en) 2020-03-17

Similar Documents

Publication Publication Date Title
CY1124717T1 (el) Μεθοδοι, kit και συσκευη για επεκταση πληθυσμου κυτταρων
WO2020123301A3 (en) Generating spatial arrays with gradients
BR112014025384A8 (pt) método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
PE20181349A1 (es) Anticuerpos biespecificos con tetravalencia para un receptor de fnt coestimulador
MX2016011982A (es) Prediccion in vitro de semivida in vivo de anticuerpos.
CO2019008675A2 (es) Anticuerpos anti-lag3 radiomarcados para la obtención de imágenes mediante inmuno-pet
JOP20170041B1 (ar) اجسام مضادة ضد vista (b7h5)
MX2017006443A (es) Proceso para efectuar la prueba de alto rendimiento de la cromatografia liquida de alta resolucion.
MX2017007617A (es) Aparato y metodos de prueba para biomarcador cardiaco st2.
MX2020003523A (es) Deteccion de dimetilarginina simetrica.
CL2015002756A1 (es) Moléculas fc biespecíficas
CR20110544A (es) Anticuerpo antagonista específico para el heterodímero de alfa-4-beta-7
ECSP088081A (es) Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente
MX2018015047A (es) Metodo para la deteccion de un anticuerpo igm especifico para un flavivirus en una muestra.
AR098126A1 (es) Anticuerpos anti-ly6e (locus e del complejo del antígeno 6 linfocítico), inmunoconjugados y métodos para usarlos
AR104264A1 (es) Neutralización del virus de chikungunya mediada por anticuerpos
BR112018007842A2 (pt) imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk)
EA201991506A1 (ru) Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
MX2017010505A (es) Inmunoensayo homogeneo con compensacion para señal de fondo.
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
EA201692071A1 (ru) Иммуноанализ и антитела для обнаружения хромогранина а
MX2019003288A (es) Proteínas de mycobacterium tuberculosis en pruebas diagnósticas y dispositivos para la detección y diagnóstico de la tuberculosis.
CO2025009790A2 (es) Anticuerpos contra la proteína de fusión (f) del metapneumovirus y usos de los mismos
MX377864B (es) Composición de antígeno para detectar enfermedad de chagas.

Legal Events

Date Code Title Description
FG Grant or registration